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Abstract A broad working definition of structural pro-
teomics (SP) is that it is the process of the high-throughput
characterization of the three-dimensional structures of
biological macromolecules. Recently, the process for pro-
tein structure determination has become highly automated
and SP platforms have been established around the globe,
utilizing X-ray crystallography as a tool. Although protein
structures often provide clues about the biological function
of a target, once the three-dimensional structures have been
determined, bioinformatics and proteomics-driven strate-
gies can be employed to derive their biological activities
and physiological roles. This article reviews the current status
of SP methods for the structure determination pipeline,
including target selection, isolation, expression, purification,
crystallization, diffraction data collection, structure solution,
refinement and functional annotation.
Keywords Protein structure analysis  X-ray
crystallography  Bioinformatics  Structural proteomics
Introduction
One of the most spectacular recent achievements in life
sciences has been the sequencing of the entire human
genome, accomplished by the Human Genome Project. The
resolution of the entire sequence of the human genome has
resolved many unanswered questions relating to human
life. The human body comprises a vast number of cells and
each cell contains many thousands of different proteins
necessary to maintain cellular function. Knowledge of the
sequence of the human genome means that disease-asso-
ciated abnormalities can now be detected at the genetic
level. Furthermore, sequence comparisons can provide an
insight into the evolutionary relationship between organ-
isms. As of August 2011, the UniProtKB/Swiss-Prot
database has contained in excess of half a million non-
redundant sequence entries. Hence, it is clear that large-
scale genomic projects have provided the sequence infra-
structure for the in-depth analysis of proteins. A new fun-
damental concept of the proteome (PROTEin complement
to a genOME) has emerged that aims to unravel the bio-
chemical and physiological mechanisms of complex mul-
tivariate diseases at the functional and molecular level. As
a consequence, the new science of proteomics has been
established to complement physical genomic research.
Proteomics can be defined as the qualitative and quanti-
tative comparison of proteomes under different conditions,
which aims to further characterize biological processes and
functional protein networks (Naistat and Leblanc 2004;
Petschnigg et al. 2011; Stults and Arnott 2005). However,
the knowledge gleaned from the various genomes
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sequenced to date is not sufficient to understand the func-
tion of proteins within the cell. To characterize functional
protein networks and their dynamic alteration during
physiological and pathological processes, proteins have to
be identified, sequenced, categorized and classified with
respect to their function and interaction partners. To
understand their functions at a molecular level, it is often
necessary to determine their three-dimensional (3D)
structures at atomic resolution.
During the past decade, the emerging field of structural
proteomics (SP) has developed, representing an interna-
tional effort aimed at the large-scale determination of the
3D structures of proteins encoded by the genomes of key
organisms (Burley 2000; Joachimiak 2009; Manjasetty
et al. 2007; Terwilliger 2011). Initiatives in SP research
have led to the development of novel strategies and auto-
mated protein structure determination pipelines around the
world (Table 1) (Chance et al. 2004; Manjasetty et al.
2008).
When protein structure analysis was first established in
the late 1960s and the X-ray structures of myoglobin and
hemoglobin were determined, the development of such a
high-throughput (HT) infrastructure for protein structure
analysis would have seemed like an impossible dream. The
remarkable success and technological advancements since
then have had a tremendous impact on throughput in pro-
tein structure determination and all stages of the pipeline
have become more or less automated (Fig. 1). Currently,
SP initiatives are generating protein structures at an
unprecedented rate and have resulted in an exponential
growth in the number of protein structures deposited in the
Protein Data Bank (Fig. 2: 65979 PDB entries, as of
August 2011). However, the number of solved protein
structures in the PDB represents only a small proportion of
the theoretical number of proteins encoded by genomic
sequences.
To bridge this gap and to meet the demand of rapidly
obtaining protein structure information, advancements
have been made in SP methodologies in the form of HT
Table 1 Major centers for high-throughput structure determination around the world
No. Country Center Web address PDB
entries
1. Japan RIKEN Structural Genomics/Proteomics Initiative http://www.rsgi.riken.go.jp/ 2,702
2. USA Midwest Center for Structural Genomics (MCSG) http://mcsg.anl.gov/ 1,389
3. USA Joint Center for Structural Genomics (JCSG) http://www.jcsg.org/ 1,234
4. USA New York Structural Genomics Research Consortium
(NYSGRC)
http://www.nysgrc.org/ 1,028
5. Canada, UK, Sweden Structural Genomics Consortium (SGC) http://www.thesgc.org/ 1,005
6. USA Northeast Structural Genomics Consortium (NESG) http://www.nesg.org/ 964
Fig. 1 Process involved in SP using X-ray crystallography
Fig. 2 Exponential growth in the number of X-ray protein structures
deposited in the Protein Data Bank
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technologies. However, these technologies have encoun-
tered some of the traditional bottlenecks in structure
determination for difficult proteins and complexes of
proteins at HT. To overcome these bottlenecks, efforts
have been focused on improving the structure determi-
nation pipeline by streamlining and optimizing protein
production, protein crystallization, data collection and
structure solution. In addition, SP centers have adopted
bioinformatics analysis of potential targets to generate
models based on solved structures and to establish col-
laborative research to exploit the function of proteins.
Recently, in the USA, the National Institutes of Health
established a Protein Structure Initiative (PSI): a biology
network to determine protein structures including mem-
brane proteins of high biological interest. The objective of
the PSI is to develop suitable technologies for membrane
protein structure solution, using bioinformatics and mod-
eling to leverage solved structures, and to carry out col-
laborative research to provide a link between a structure
and its biomedical and biotechnological impact. On the
other hand, in Europe, the emphasis for the Structural
Proteomics IN Europe (SPINE) initiative has been to
apply these HT technologies to systems of biological
interest, the ultimate aim being to solve significant bio-
logical problems more effectively. Furthermore, the
European INSTRUCT project offers scientists access to
world-class structural biology and SP infrastructures and
expertise. INSTRUCT makes integration possible more
rapidly, creating a coherent forum for structural biology.
This forum will stimulate closer collaboration between
scientific communities and initiatives in biological
sciences.
In this report, recent advances in protein structure
analysis in the context of SP will be discussed. Further-
more, the impact of SP on other biological sciences
including drug discovery and biotechnology will be
explored.
Automation and strategies for protein structure
analysis
Protein production and crystallization
Generating pure, soluble and homogeneous protein for
structure determination is a major rate-limiting step in the
overall process. Traditional sequential generation of single
expression constructs for a single protein target has been
superseded by parallel, HT cloning techniques. Genetic
engineering and the use of specific crystallization chaper-
ones are two approaches that have proven invaluable for
the determination of many highly important protein
structures.
Screening of candidate proteins
Structural biology projects are typically initiated to char-
acterize the biological activity of a specific protein or
protein complex. In some cases, crystallization of that
exact protein leads to a structure that can be correlated
directly to functional data. However, in many cases,
researchers will eventually come to the conclusion that the
protein of interest is not suitable for structural analysis. It
makes sense, therefore, to include parallel, HT approaches
early on for identifying optimal boundaries and experi-
mental conditions for protein production and crystalliza-
tion. The selection of candidate proteins is very much
project dependent, but will usually include orthologs or
homologs of the original protein of interest and genetic
constructs corresponding to subregions or individual
domains. Methods for HT characterization of larger num-
bers of expression clones have originally been described
for bacterial expression systems (Berrow et al. 2006;
Bu¨ssow et al. 2005). Small-scale expression testing is more
difficult to achieve in eukaryotic systems such as yeast
(Holz et al. 2003) and baculovirus (McCall et al. 2005).
Transient transfection of mammalian cell lines such as
HEK293 is a highly efficient system for secreting mam-
malian glycoproteins and has also been successfully
applied to produce membrane proteins such as rhodopsin
(Standfuss et al. 2011). This method can be performed in a
HT manner for characterization of protein candidates for
crystallization (Lee et al. 2009).
Glycoproteins
The choice of expression system has a great influence on
the quality and quantity of the produced recombinant
protein. Cell-free protein production has proven its value
for producing soluble (Makino et al. 2010) and membrane
proteins (Junge et al. 2011; Reckel et al. 2010) for NMR
and crystallographic studies (Watanabe et al. 2010).
Mammalian proteins stabilized by disulfide bonds and
modified by glycosylation are especially demanding tar-
gets. Mammalian cells are the ideal host for these proteins,
since they yield protein with all the post-translational
modifications required for biological activity, including
authentic glycosylation and correct disulfide pairing.
However, cell culture is time and labor intensive. Many
extracellular mammalian proteins can be recovered in
active form through refolding of bacterial inclusion body
proteins (Vallejo and Rinas 2004). Obviously, these pro-
teins do not require post-translational modifications other
than disulfide bridges for correct folding. Refolding of
proteins from inclusion bodies is common in industrial
production but requires extensive process optimization.
Structural biology projects applying inclusion body
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refolding benefit from automated screening of folding
conditions with generic, biophysical assays (Cowieson
et al. 2006; Scheich et al. 2004; Vincentelli et al. 2004).
Animal cell lines are highly effective for the secretion
of proteins with native glycosylation and disulfide bonds.
Glycoproteins produced with the mammalian CHO or
HEK293 cell lines carry heterogeneous, complex-type
oligosaccharide chains attached to Ser/Thr (O-linked) or
Asn (N-linked) side chains. Crystallization of glycopro-
teins is difficult because of the heterogeneity and flexible
conformation of the bulky oligosaccharides, which can
also mask possible sites of crystal contacts on the protein
surface. Some glycosylation sites can be removed by
mutagenesis. Regions with O-linked glycosylation are
generally proline-rich and unfolded, and can be excluded
from genetic constructs. However, many proteins require
glycosylation for folding and transport through the
secretory pathway. Enzymatic removal of N-linked gly-
cans from the purified protein with endoglycosidase H or
F leaves a single monosaccharide attached, which may
increase the solubility of the deglycosylated protein.
Enzymatic deglycosylation is efficient for oligosaccha-
rides of the high-mannose type as obtained from the
baculovirus system (Fig. 3a). Processing of N-linked
glycans by mammalian cell lines results in complex-type
oligosaccharides that are difficult to cleave enzymatically.
Complex-type glycosylation can be prevented by chemi-
cal glycosylation inhibitors (Chang et al. 2007) or by
mutating the host cells. The gene for the enzyme N-
acetylglucosaminyl-transferase I (GnTI), which modifies
high-mannose type oligosaccharides, has been mutated in
the cell lines CHO Lec1, Lec3.2.8.1 (Stanley 1989) and
HEK293S-GnTI(-) (Reeves et al. 2002). These cell lines
and normal HEK293 cells treated with the glycosylation
inhibitors kifunensine or swainsonine have enabled the
production of many glycoproteins and their crystallization
upon enzymatic deglycosylation (Aricescu et al. 2006;
Chang et al. 2007; Davis et al. 1993; Standfuss et al.
2011). Optimized protocols and cell lines allow per-
forming transient transfection of HEK293 at up to liter
scale with inexpensive reagents (Aricescu et al. 2006).
However, not all proteins can be produced in sufficient
amounts by transient transfections. Stable cell lines allow
the production of proteins more reproducibly and in much
larger volumes in bioreactors. However, establishing lines
with good performance requires considerable effort.
Novel approaches of stable cell line development, based
on preparative cell sorting and recombinase-mediated
cassette exchange (RMCE Fig. 3c), combine faster
development times with improved performance and have
been used successfully for X-ray crystallography studies
(Wilke et al. 2010, 2011).
Fig. 3 Protein production.
a Glycosylation: structure of a
high mannose-type glycan.
b Co-expression of a complex
of four proteins with the pQLink
system. M: marker, W: whole
cellular protein, P: purified
protein (Scheich et al. 2007).
c Cell line development by
recombinase-mediated cassette
exchange (RMCE): cells are
transfected with a vector
containing a GFP gene flanked
by recombination sites F3 and F
and GFP-positive cells are
isolated. Cassette exchange is
initiated by co-transfecting a
tagged cell line with an Flp
recombinase expression vector
and a targeting vector bearing
the gene of interest (GOI). Flp
recombinase exchanges the
tagging gene cassette and a
production cell line is obtained
(Wilke et al. 2011)
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Crystallization chaperones
Some protein families require a combination of specialized
strategies for successful crystallization. Crystallization
chaperones are proteins that specifically bind to the target
protein and support ‘‘carrier-driven’’ crystal growth
(reviewed by (Koide 2009)). They limit the conformational
flexibility of the target protein and provide a large,
hydrophilic interaction surface for initiating crystal lattice
contacts. Fab fragments of monoclonal antibodies have
been used traditionally as crystallization chaperones. In
addition, recombinant antibodies from camels (VHHs, also
called ‘‘nanobodies’’) and synthetic scaffold proteins have
demonstrated their usefulness in many examples (Koide
2009). Disulfide-free synthetic scaffold proteins such as
designed ankyrin repeat proteins (DARPINs) or the fibro-
nectin type III domain (FN3) can be screened for specific
binders in vitro and can be produced easily in E. coli. Fab
fragments enabled the first crystal structure to be deter-
mined for a non-rhodopsin GPCR (Rasmussen et al. 2007)
and a full-length potassium channel (Uysal et al. 2009).
Furthermore, the first high-resolution crystal structure of
the b2 adrenergic receptor–Gs protein complex has
recently been reported in which nanobodies (camelid
antibody fragments) were used to significantly improve
crystal quality (Rasmussen et al. 2011). Nanobodies are
relatively simple proteins, about a tenth the size of anti-
bodies and just a few nanometers in length.
Protein engineering
Protein engineering can overcome problems with produc-
ing sufficient amounts of protein, keeping protein soluble at
the concentrations required for crystallization and obtain-
ing proteins with surfaces that allow crystal formation
(Derewenda 2010). In general, protein engineering follows
one of three strategies: designing shortened proteins lack-
ing terminal residues outside the globular fold, mutating
residues on the target protein’s surface or designing fusion
proteins.
If a full-length protein cannot be produced or crystal-
lized, then a common strategy is to design shorter variants
which represent isolated domains, eliminating flexible
regions at the termini or large internal loops. Databases
such as PFAM provide information on the presence of
conserved domains in protein sequences. Alternatively,
genetic constructs can be designed that avoid regions pre-
dicted to be disordered and unfolded by software tools such
as DISOPRED2 (Ward et al. 2004), RONN (Yang et al.
2005), or the meta-server metaPrDOS (Ishida and Ki-
noshita 2008). The strategy of designing genetic constructs
on the basis of computational analysis may fail because of
imprecise or missing information in the respective
databases. Robotic screening of random truncation libraries
represents an alternative technique in such cases (reviewed
by (Dyson 2010; Yumerefendi et al. 2011)). In this tech-
nique, the cDNA is fragmented and a library of expression
clones is created by cloning the fragments. By chance, a
few clones of the library will contain a fragment that
encodes for just one complete domain. Such clones will
express soluble protein. Different ways of screening
libraries for clones that express soluble protein have been
described, including a filtration technique (Cornvik et al.
2005), the biotinylation assay of the ESPRIT technology
(Yumerefendi et al. 2011) and screening based on GFP
fusion protein fluorescence (Pedelacq et al. 2011). The
ESPRIT (Expression of Soluble Proteins by Random
Incremental Truncation) library technology has been
adapted recently to allow screening for soluble protein
complexes (An et al. 2011).
Single point mutations can have a dramatic effect on a
protein’s solubility and crystal formation (Derewenda 2010).
The most successful point mutation strategy, surface entropy
reduction (SER), replaces small clusters of two to three
surface residues with high conformational entropy such as
Lys, Glu or Gln with Ala. SER produces mutants that are
often more susceptible to crystallization than the wild-type
protein. More than 100 structures of proteins optimized by
SER have been solved. A Web server facilitates protein
engineering for SER (http://services.mbi.ucla.edu/SER/). In
general, SER does not improve protein solubility. Proteins
that cannot be concentrated to sufficient levels for crystal
growth benefit from strategies opposite to SER. The solu-
bility of such proteins can often be increased by reducing the
hydrophobicity of surface residues. This approach is more
difficult than SER, because exchanging hydrophobic surface
residues requires some knowledge of the protein’s structure.
Directed point mutations are generally not used to
improve the protein production levels since no rational
strategies are available. However, screening of large
libraries of random mutants of the target proteins, enabled
by laboratory automation, has been successful (Cornvik
et al. 2005; Listwan et al. 2009; Yumerefendi et al. 2011).
Fusion proteins with partners such as glutathione S-trans-
ferase (GST), thioredoxin or maltose binding protein
(MBP) are a more common approach to improve the target
protein’s production and solubility. However, the flexible
linker between the fusion partners generally inhibits crys-
tallization. Furthermore, when the fusion partner is
removed using a site-specific protease, the improvement in
solubility conferred by the fusion partner may be lost.
Careful design of MBP fusion proteins enables carrier-
driven crystallization of intact fusion proteins (Moon et al.
2010). These fusions have to be designed in such a way that
the MBP’s C-terminal a-helix is fused directly to the
globular core of the target protein, thereby avoiding
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flexibility between the fusion partners. Then, the MBP part
can improve protein yield and solubility and promote
crystal growth.
One method of surface modification that does not
involve additional cloning is reductive lysine methylation,
where lysine side chains are chemically modified (Sledz
et al. 2010; Walter et al. 2006). The technique can improve
the X-ray diffraction of existing crystals, or permit the
crystallization of proteins that had previously failed to
yield crystals.
Protein complexes
Protein complexes are attractive targets for X-ray crystal-
lography, because their structures reveal important infor-
mation relating to the molecular details of specific protein
recognition. However, crystallization of a complex
requires careful preparation that includes critical assess-
ment of the available data, careful optimization of sample
preparation and functional and biophysical characterization
of the complex using a variety of methods (Collinet et al.
2011; Perrakis et al. 2011). Very stable complexes that do
not dissociate are preferred targets for crystallization.
However, the subunits of such stable heterocomplexes may
not be able to fold into a soluble conformation alone,
necessitating the co-expression of the complex compo-
nents. Transient complexes, on the other hand, which exist
in equilibrium with the dissociated subunits, are more
difficult to crystallize because of sample heterogeneity.
Subunits of transient complexes may form crystals that
exclude the other subunit, which is often difficult to detect.
Recombinant production of the subunits of a protein
complex in the same host cell by co-expression has been
described with a large variety of systems (Busso et al.
2011; Nie et al. 2009; Vijayachandran et al. 2011). Novel
cloning strategies enable co-expression of many subunits
in host cells including E. coli, baculovirus and mammalian
cells (Berger et al. 2004; Kriz et al. 2010; Trowitzsch et al.
2010), and have been adapted to automated cloning (Bi-
eniossek et al. 2009). The pQLink system (Scheich et al.
2007) allows co-expression of an unlimited number of
protein subunits in E. coli with different affinity tags
(Fig. 3b). pQLink vectors have been widely used by dif-
ferent laboratories, mainly for eukaryotic vesicle tethering
complexes (Kummel et al. 2008; Lees et al. 2010; Ren
et al. 2009). Studies comparing a large variety of expres-
sion systems have demonstrated that subtle changes in the
expression strategy have a profound effect on the success
of co-expression experiments, even if the main parameters,
protein sequence and host cell are identical (Busso et al.
2011).
Successful recombinant expression of protein complexes
requires that the subunits are synthesised in similar
amounts. Otherwise, the yield of the complete complex is
determined by the subunit present in the lowest concen-
tration. Also, a heterogeneous mixture of the complete
complex with smaller oligomers not comprising all sub-
units is obtained. To circumvent this problem, the synthesis
of polyproteins has been introduced for generating protein
complexes (Vijayachandran et al. 2011). This strategy is
reminiscent of the genomes of many viruses that contain
large open reading frames encoding polyproteins that are
cleaved by viral proteases into single proteins upon trans-
lation. A baculovirus vector containing a large open read-
ing frame comprising single protein sequences separated
by a site-specific protease site was created. The coding
sequence of the TEV protease was included in the vector.
Upon overexpression, intracellular TEV protease cleaved
the polyprotein into single subunits of a protein complex.
This strategy was successfully demonstrated for sub-com-
plexes of human general transcription factor TFIID and
other complexes (Vijayachandran et al. 2011).
Protein crystallization methods and automation
Production of protein crystals suitable for structural studies
poses one of the major bottlenecks in the entire process.
Finding crystallization conditions that yield single, well-
ordered crystals with low mosaicity that diffract to suffi-
cient resolution can be very challenging. The quality of a
crystal is often linked to the number of crystals formed (a
few large crystals versus many microcrystals), size (larger
is better) and appearance (optically clear, sharply faceted
crystals are best). However, any true measure of quality
must verify that the diffraction properties correlate with the
morphological quality of the crystal.
Crystallization can occur spontaneously, or alternatively
it can take several days, weeks or months for crystals to
appear. Longer crystallization times are usually indicative of
proteolytic cleavage at the protein termini promoting crystal
formation. It is not easy to provide an estimate for maximum
protein crystal growing time. There have been some reports
showing that, in some cases, protein crystals may take as
long as 6 months or a year to appear. However, an average
growing time for a protein crystal is typically less than a
month. Normally, protein crystallization occurs when the
concentration of protein in solution is greater than its limit of
solubility, so that the protein solution becomes supersatu-
rated. To crystallize a protein, it undergoes slow precipita-
tion from an aqueous solution. As a result, individual protein
molecules align themselves in a repeating series of ‘‘unit
cells’’ by adopting a uniform orientation. One unavoidable
aspect of crystallizing a newly expressed protein is the need
to carry out a large number of experiments to find suitable
conditions in which the protein crystallizes. It can be
extremely tedious and time consuming to set up a broad
94 3 Biotech (2012) 2:89–113
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array of different crystallization experiments manually.
With the advent of HT liquid handling and crystallization
systems, it is relatively easy to prepare a thousand or more
crystallization experiments in which crystallization param-
eters, such as the ionic strength, pH, protein and precipitant
concentration and temperature, are varied systematically.
However, the success rate does not depend upon the number
of crystallization conditions tested.
Methods used for crystallization include vapor diffusion,
batch crystallization, dialysis, seeding, free-interface dif-
fusion and temperature-induced crystallization. The most
popular method for setting up crystallization experiments is
vapor diffusion, which includes hanging drop (for smaller
volumes), sitting drop (for larger volumes), the sandwich
drop, reverse vapor diffusion and pH gradient vapor dif-
fusion methods. A drop containing a mixture of precipitant
and protein solution is sealed in a chamber with pure
precipitant. Water vapor subsequently diffuses from the
drop until the osmolarity of the drop and the precipitant is
equal. The dehydration of the drop causes a slow concen-
tration change of both protein and precipitant until equi-
librium is achieved, ideally in the crystal nucleation zone
of the phase diagram (Dessau and Modis 2011). Batch
crystallization relies on bringing the protein directly into
the nucleation zone by mixing protein with the appropriate
amount of precipitant. The batch method is usually carried
out under oil to prevent the diffusion of water out of the
drop (Chayen 1997). Many of these methods can be per-
formed using HT automated instrumentation and minia-
turization of crystallization experiments and have had huge
impacts on protein crystallization in terms of saving time
and conserving precious sample. For example, crystalliza-
tion robots such as the PhoenixTM RE (Rigaku Corpora-
tion) and the Mosquito (TTP Labtech), which can
accurately and reproducibly dispense very small volumes
(nl in size) into 96-well plates for automated screening and
optimization of crystallization conditions, are now com-
monplace in many laboratories (Fig. 4). In addition, TTP
Fig. 4 Protein crystallization




set-ups, additive screening and
microseeding; b TTP LabTech’s
mosquito LCP: a dedicated
instrument for crystallising
membrane proteins using lipidic
cubic phase screening. The
panel highlights the positive
displacement syringe, which
dispenses the highly viscous
lipid mesophases used in the
LCP technique into 96-well
crystallization plates. (c and
d) Crystallization plate set up
for hanging drop vapor
diffusion experiments;
e nanoliter sitting drop
experiments set up in a 96-well
plate. (Images courtesy of TTP
LabTech Ltd, UK)
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LabTech’s Mosquito LCP (Lipid Cubic Phase) has been
designed to aid in the crystallization of membrane proteins
by accurately dispensing nanoliter quantities of highly
viscous lipids or detergents that are required to retain the
structural integrity of the sample. A recent development in
protein crystallization has been the use of high-density,
chip-based microfluidic systems for crystallizing proteins
using the free-interface diffusion method at nanoliter scale,
including Emerald Biosystems MPCS (Microcapillary
Protein Crystallization System)(Gerdts et al. 2008), Flui-
digm Corporations TOPAZ system (Segelke 2005) and
the Microlytic Crystal Former (Stojanoff et al. 2011).
These platforms have the advantage of using minimal
protein sample to screen a broad range of crystallization
conditions. The Rigaku CrystalMationTM system was set
up to fully automate the crystallization process while
dealing with sample volumes of 100 nl per experiment.
A popular strategy for the optimization of crystallization
conditions in vapor diffusion is crystal seeding. Seeding
decouples nucleation from crystal growth and involves
transferring previously obtained seed crystals into under-
saturated drops. Homogeneous seeding techniques include
microseeding, streak seeding and macroseeding. Seed stock
for microseeding can be conveniently generated using
Hampton Research’s Seed Bead kit. More recently, a
simple, automated microseeding technique based on mi-
croseed matrix screening has been developed (D’Arcy et al.
2007). This method consists of the addition of seeds into
the coarse screening procedure using a standard crystalli-
zation robot and has been shown to not only produce extra
hits, but also generate better diffracting crystals. Successful
cases for a simple semi-automated microseeding procedure
for nanoliter crystallization experiments have also been
recently described (Walter et al. 2008). Furthermore,
crystallization plate storage and inspection are now fully
automated. For example, the MinstrelTM drop imager
family (Rigaku) and Rock Imager (Formulatrix) combine
imagers with gallery plate hotels/incubators to store crys-
tallization plates at a constant temperature, periodically
inspect them and manage the data (Hiraki et al. 2006;
Walter et al. 2005).
Despite the progress that has been made in increasing
throughput, the act of identifying crystals in the crystalli-
zation experiments remains a task requiring human inter-
vention. A number of attempts are being made to automate
crystal detection from the imaged drop and varying degrees
of success have been reported (Liu et al. 2008). Automated
crystal recognition has the potential to reduce the time-
consuming human effort for screening crystallization drop
images. Several approaches have been suggested to
increase contrast for imaging and detection of protein
crystals in such cases: crystal birefringence (Echalier et al.
2004), addition of fluorescent dyes (Groves et al. 2007) and
monitoring the fluorescence of trace labeled protein mol-
ecules (Forsythe et al. 2006). The identification of crys-
tallization hits has been simplified by UV detection
combined with conventional imaging (Judge et al. 2005).
For example, the latest generation of imaging systems
combine visible and UV inspections providing a powerful
tool for monitoring crystallization trials: when crystals are
still too small to be mounted, the intrinsic protein fluo-
rescence signal gives confidence that a crystallization hit is
worth pursuing. Second-order nonlinear optical imaging of
chiral crystals (SONICC) is an emerging technique for
crystal imaging and characterization (Kissick et al. 2010,
2011). SONICC imaging has been found to compare
favorably with conventional optical imaging approaches
for protein crystal detection, particularly in non-homoge-
neous environments that generally interfere with reliable
crystal detection by conventional means.
A recent development is the X-CHIP (X-ray Crystalli-
zation High-throughput Integrated Platform): a novel
microchip that provides a stable microbatch crystallization
environment and combines multiple steps of the crystal-
lographic pipeline from crystallization to diffraction data
collection onto a single device (Kisselman et al. 2011).
This system facilitates HT crystallization screening, visual
crystal inspection, X-ray screening and data collection. The
chip eliminates the need for manual crystal handling and
cryoprotection of crystal samples while allowing data
collection from multiple crystals in the same drop.
Data collection and processing
Data acquisition involves the recording of a series of X-ray
diffraction images using a detector. The process of crystal
mounting, centering, exposing with X-rays, recording dif-
fraction data and dismounting the crystal represent the
major steps in crystallographic data collection.
Radiation source, crystal handling and detector: past
and present tools
In the past, protein crystals typically ranging in size from
tenths of a millimeter to several millimeters were mounted
in glass capillary tubes. To collect data, the capillary tube
was mounted on a goniometer and exposed to X-rays at
room temperature. These X-rays were generated by low
flux, sealed tube sources. Nowadays, data collection is
handled by automated sample changers and micro-dif-
fractometers in a cryogenic (100 K) environment utilizing
brighter synchrotron radiation as the X-ray source. Cryo-
freezing the sample inhibits free radicals diffusing through
the crystal during data collection: these free radicals cause
secondary radiation damage that leads to degradation in the
quality of collected data. There are currently in excess of
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125 dedicated protein crystallography beamlines around
the World. The X-ray films that were used for data
recording in the past have now been superseded with
charge-coupled devices (CCD) and pixel array detectors,
which allow diffraction data to be recorded directly and
stored straight to disk. For example, a recent development
has been the PILATUS detector (pixel apparatus for the
SLS), which has no readout noise, superior signal-to-noise
ratio, a readout time of 5 ms and high dynamic range
compared to CCD and imaging plate detectors. Delivery of
high flux beam at third-generation synchrotron sources
coupled with the advances in detector technology and
control systems have significantly accelerated the speed of
macromolecular diffraction data collection. An example of
a state-of-the-art synchrotron X-ray data collection setup is
shown in Fig. 5. Nowadays, crystals larger than 50 lm in
size can be evaluated at conventional synchrotron beam-
lines. However, with some targets such as membrane
proteins and multi-protein complexes, it is notoriously
difficult to obtain crystals of sufficient size and order to
generate high-quality diffraction data. Hence, next gener-
ation microfocus beamlines with reduced beam sizes have
been established at synchrotron sites around the world,
allowing measurements to be made on crystals a few
micrometers in size. It has been predicted that a complete
data set with a signal-to-noise ratio of 2r at 2 A˚ resolution
could be collectable from a perfect lysozyme crystal
measuring just 1.2 lm in diameter using a microfocus
beam (Holton and Frankel 2010). A number of crystal
structures have been solved using micrometer-sized crys-
tals by merging data from several crystals, including a
polyhedron-like protein structure (*5–12 lm) (Coulibaly
et al. 2007) and a thermally stabilized recombinant rho-
dopsin (with crystal dimensions of 5 9 5 9 90 lm3)
(Standfuss et al. 2007). Recently, strategies have been
developed to determine structures from showers of
microcrystals using acoustic droplet ejection (ADE) to
transfer 2.5 nl droplets from the surface of microcrystal
slurries through the air and onto micromesh loops. Indi-
vidual microcrystals are located by raster-scanning a sev-
eral-micron X-ray beam across the cryocooled
micromeshes. X-ray diffraction data sets are subsequently
merged from several micrometer-sized crystals and this
technique has been used to solve 1.8 A˚
´
resolution crystal
structures (Soares et al. 2011).
As a result of these technological advancements, the time
required to setup a diffraction experiment has become a
significant proportion of the total time of an experiment.
The diffraction experiment involves sample mounting,
crystal centering and determination of data collection
parameters. Significant progress has been made in auto-
mating crystal mounting, crystal centering and the energy
scan to find metals or ions present in crystals that can be
used for phasing (Heinemann et al. 2003; Shi et al. 2005).
Automated sample mounting systems allow users to mount
samples on the beamline without entering the experimental
hutch. These systems minimize the need for manual inter-
vention and facilitate the rapid and systematic screening of
dozens of samples. For example, the automated sample
changers equipped at the EMBL/ESRF beamlines are
capable of handling 50 frozen samples, whereas the ACTOR
(Automated Crystal Transfer, Orientation and Retrieval)
robots installed on the beamlines at the DIAMOND syn-
chrotron can mount up to 80 cryogenically frozen samples
from their onboard storage dewars. This facilitates the rapid
screening and ranking of crystals and enables users to col-
lect data from their best diffracting crystal(s) (Beteva et al.
2006; Cipriani et al. 2006). These features make the auto-
mated approach far quicker than manual operations insuring
that beamtime is used efficiently.
Before starting data collection, the crystal needs to be
aligned so that it is coincident with the X-ray beam and the
Fig. 5 X-ray data collection facility. a End-station instrumentation at
ESRF beamline BM14 (http://www.bm14.eu) illustrating the sample
changer used to exchange cryo-frozen crystals on the goniometer and
the MARCCD (Marresearch GmbH) detector used to collect dif-
fraction images. The arrow highlights the path of the X-ray beam.
b Close-up view showing the frozen crystal sample in the center of
the image and the surrounding beamline instrumentation. The red
cross and blue circle represent the center and diameter of the X-ray
beam on the frozen crystal sample (bottom right)
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rotation axis. This is normally performed manually by the
user at the beamline. However, for fully automated oper-
ation of the beamline, automated crystal centering is a
prerequisite, especially when sample mounting robots are
used. Semi-automated crystal centering based on a user
clicking a mouse to indicate the position of the crystal
through a specially designed software interface has been
shown to be relatively robust and is employed at most
synchrotron beamlines (Snell et al. 2004). Recent reports
show that it is possible to center crystals automatically
without user intervention using the recognition software
C3D (Lavault et al. 2006), XREC (Pothineni et al. 2006) or
alternatively by using the diffraction method (Hilgart et al.
2011; Song et al. 2007). Crystal centering based on the
diffracton method is especially attractive for micrometer-
sized crystals. Optical centering of small crystals is chal-
lenging since visible light wavelengths (0.4–0.7 lm) are
comparable to the crystal size and many crystals have
irregular diffraction quality, which cannot be addressed by
this technique. In diffraction-based crystal centering, the
crystal is scanned in two dimensions using a small step size
and at each step a diffraction image is taken, which is
analyzed for locating and counting diffraction spots. The
scored results are presented in a table which allows users to
select optimally diffracting areas within the macroscopic
sample (Cherezov et al. 2009).
Data collection and processing software packages
Typically, data extending to 2.5 A˚ resolution or higher are
desirable for novel proteins and protein–ligand complexes,
so that the model can be fitted unambiguously into the
electron density map. However, in more challenging cases,
data at 3 A˚ resolution or lower may be sufficient to fit the
overall fold of a protein or the constituents of a multi-
protein complex. A typical X-ray diffraction image, the
electron density map to atomic resolution and the distri-
bution of resolutions for protein structures in the PDB are
depicted in Fig. 6. However, in many cases, diffraction
properties of crystals are not known in advance, especially
when crystals are small (in the micrometer range) and
cannot be prescreened using in-house instrumentation prior
to a synchrotron trip. It often takes a significant amount of
time at the synchrotron to screen these sub-micron crystals
Fig. 6 Accuracy and details.
a Representative X-ray
diffraction pattern collected on a
Marresearch GmbH imaging
plate system. The diffraction
extends to a maximum of 1.9 A˚
resolution at the edge of the
image. b Representative portion
of an electron density map at
0.96 A˚ resolution. The sticks
represent the individual atoms
for the amino acids that
constitute the protein (carbon,
gray; nitrogen, blue; oxygen,
red; sulfur, yellow) and the
chicken wire represents the
corresponding experimental
electron density for these atoms.
c Histogram depicting the
distribution of resolutions for
protein structures in the PDB as
of August 2011
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to identify a well-diffracting crystal suitable for data col-
lection. Whilst collecting data at the synchrotron beamline,
the user must make decisions about the parameters of the
experiment—exposure time, rotation range, oscillation
angle, detector distance, beam size and wavelength—based
on their experience, visual inspection of the diffraction
images and information output by data-processing pack-
ages. Most of the instrumentation in the experimental sta-
tion is computationally controlled using software packages
such as Blu-Ice (McPhillips et al. 2002), CBASS (Skinner
et al. 2006), MxCube (Gabadinho et al. 2010) and JBlue-
Ice (Stepanov et al. 2011). However, very often an intuitive
decision is made by the user on the exposure time to use. In
cases where this has been overestimated, it can lead to
significant radiation damage before the completion of data
collection. In addition, an inappropriate data collection
strategy can lead to the failure of an experiment. Compu-
tationally efficient modeling of the data statistics for any
combination of data collection parameters provides a
foundation for making a rational choice. The modeling of
data statistics using a few test images allows one to
quantitatively select which screened crystal gives the
highest resolution using an appropriate rotation range and
X-ray radiation dose prior to data collection (Bourenkov
and Popov 2006, 2010).
The evaluation of the collected reflection intensities on
the diffraction images involves the integration of the total
intensity within all pixels of the individual spot profiles. The
crystallographic program HKL2000 is capable of carrying
out data processing automatically (Borek et al. 2003; Minor
et al. 2006). Other commonly used data-processing pack-
ages include XDS (Kabsch 1993) and MOSFLM (Leslie
2006). These programs all give excellent results with high-
quality diffraction data, although their treatment of imper-
fect data differs owing to different approaches to indexing,
spot integration and the treatment of errors. These programs
can process data from a wide variety of modern area
detectors from manufacturers including MarResearch, Rig-
aku/MSC, ADSC and MacScience. All these programs
require crystallographers to make informative decisions and
to input the correct experimental parameters to process the
data successfully. There are ongoing activities at several
synchrotron beamlines to develop expert systems that aim to
automate the data collection strategy using the software
BEST (Bourenkov and Popov 2006), RADDOSE (Paithankar
and Garman 2010), MOSFLM and XDS to reduce the time
required to successfully collect high-quality X-ray data.
Post-crystallization treatments to improve the quality
of diffraction
Among the biggest problems in macromolecular crystal-
lography is the relatively weak diffraction power of protein
crystals and their sensitivity to ionizing radiation damage.
Cryogenic methods provide great advantages in macro-
molecular crystallography, especially when synchrotron
radiation is used for diffraction data collection. Apart from
reducing the problem with radiation damage and enabling
the storage and safe transport of frozen crystals, there are a
number of additional benefits. For example, cryo-freezing
can be exploited to trap normally unstable intermediates in
enzyme-catalyzed reactions to permit their characteriza-
tion. In addition, cryo-freezing can dramatically improve
diffraction properties by reducing thermal vibrations and
conformational disorder within the crystal, provided that
the crystal is amenable to freezing and a suitable cryo-
protectant has been selected. Of primary practical impor-
tance is the decrease in secondary radiation damage in the
crystal caused by the diffusion of free radicals, typically
permitting a complete data set to be collected from a single
crystal. Cryogenic data collection has allowed efficient
phasing using multi-wavelength methods.
When a crystal of a biological macromolecule is cooled
to cryogenic temperatures, the main difficulty is to avoid
the crystallization of any water present in the system,
whether internal or external. Therefore, a cooling proce-
dure has to be chosen that leads to a glass-like amorphous
phase of the solvent. In principle, there are four options: (1)
cooling on a timescale too fast for ice formation to occur
(Hartmann et al. 1982), (2) cooling at high pressure by
which the formation of the common hexagonal form of ice
is circumvented (Thomanek et al. 1973), (3) replacing the
liquid surrounding the crystal with a water-immiscible
hydrocarbon oil such as paratone-N (Hope 1988, 1990),
paraffin oil (Riboldi-Tunnicliffe and Hilgenfeld 1999) and
LV CryoOilTM (MiTeGen), (4) modifying the physico-
chemical properties of the solvent by the addition of cry-
oprotectants in a way that a vitrified state can be reached at
moderate cooling rates.
To prevent the nucleation of ice crystals, the last method
is currently the most widely used. The crystal is permeated
with a diffusible solvent containing cryoprotectants such as
glycerol, sucrose or other organic solvents (Garman 1999;
Garman and Owen 2005; Heras and Martin 2005). Deter-
mining the initial and optimal cryoprotectant concentration
is often a process of trial and error. One must find suitable
cryoprotectant concentrations that do not destroy the
crystalline order while, at the same time, allowing the
solvent to form an amorphous glass upon rapid cooling.
Recently, trimethylamine N-oxide (TMAO) has been
shown as a very versatile cryoprotectant for macromolec-
ular crystals (Mueller-Dieckmann et al. 2011).
It has been shown that diffraction properties of flash-
cooled macromolecular crystals can often be improved by
warming and then cooling a second time—a procedure
known as crystal annealing. Two different crystal-
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annealing protocols have been reported (Garman 1999;
Harp et al. 1998, 1999; Samygina et al. 2000; Yeh and Hol
1998) and many variants of these have been tried in the
field. The first method involves removing a flash-cooled
crystal from the cold gas stream and placing it in a cryo-
protectant solution (either glycerol, MPD or Paratone-N
oil) for several minutes before refreezing (Harp et al. 1998,
1999). There are several examples cited in the literature
where this technique has been successfully applied (Felts
et al. 2006; Manjasetty et al. 2001). In the second method,
the cold stream is blocked for a fixed amount of time before
the crystal is allowed to re-cool (Yeh and Hol 1998). Both
annealing protocols can improve crystal resolution and
mosaicity, although substantial crystal-to-crystal and mol-
ecule-to-molecule variability has also been observed.
Recently, the flash annealing technique has been automated
using a cryo-shutter (Vahedi-Faridi et al. 2005), a device
that blocks the 100 K nitrogen stream that bathes the
crystal for a specific amount of time. The main advantage
of the shutter system is that it allows a controlled, instant
re-cooling of the crystal and the user can perform the flash
annealing experiment remotely without entering the
experimental hutch.
Diffraction quality can also be improved by post-crys-
tallization treatments, such as controlled dehydration
(Heras et al. 2003), to attempt to improve the crystal dif-
fraction properties. A user-friendly apparatus for crystal
dehydration has been designed and implemented at the
ESRF/EMBL beamlines (Russi et al. 2011; Sanchez-
Weatherby et al. 2009). In addition, Proteros biostructures
GmbH has developed a Free Mounting System (FMSTM)
that precisely controls the humidity around a crystal, which
can lead to dramatically improved diffraction data.
Remote data collection
Synchrotron data collection can be performed remotely
from home institutions by accessing the instrumentation
via advanced software tools that enable the network-based
control of beamlines (Gonzalez et al. 2005). Remote access
to synchrotron sources is becoming more popular, since it
saves both time and resource and results in more efficient
use of the beamtime. ‘‘Mail-in’’ crystallography (diffrac-
tion data measured by synchrotron staff) is another popular
option for X-ray diffraction data collection, whereby users
ship their crystals to the synchrotron for data collection by
the beamline scientists.
X-ray structure determination
Amplitudes or intensities can be measured directly from the
X-ray diffraction experiment, but information relating to
their relative phases cannot be measured. To be able to
calculate an electron density map and subsequently deter-
mine the protein structure, an estimate of the phases has to be
obtained indirectly using mathematical approaches and this
represents the phase problem in protein crystallography.
Structure determination methods
Heavy-atom incorporation (isomorphous replacement,
anomalous scattering and anomalous dispersion), molecu-
lar replacement and direct methods are commonly used
techniques to solve protein structures. The general
requirement for the exploitation of the anomalous signal
for the determination of phase estimations via multiple or
single-wavelength anomalous diffraction (MAD or SAD)
techniques is that the protein crystal should contain
anomalously scattering atoms, e.g., Hg, Pt or Se. With the
advent of tunable X-ray sources and improved data col-
lection techniques, it is now possible to measure the
intensities of diffracted X-rays with very high precision.
The small differences in intensities between Bijovoet pairs
due to the presence of heavy atoms can be used to calculate
initial estimates of the protein phase angle. One of the
strategies widely used for the determination of novel pro-
tein structures is selenomethionine incorporation, where
selenomethionine is replaced by methionine in the protein
during expression. This method has revolutionized protein
X-ray crystallography and it is estimated that over two-
thirds of all novel crystal structures have been determined
using either Se-SAD or Se-MAD (Fig. 7a). Novel struc-
tures can also be solved using the weak anomalous signals
from atoms, such as sulfur and phosphorous present in
certain macromolecules. SAD represents the most com-
monly used technique for novel proteins in SP centers.
Multiple or single isomorphous replacement (MIR or SIR)
methods also require the introduction of heavy atoms such
as mercury, platinum, uranium or gold into the macro-
molecule under investigation. These heavy atoms must be
incorporated into protein crystals without disrupting the
lattice interactions so that it remains isomorphous with
respect to the native crystal. In the SIR method, intensity
differences between the heavy-atom derivatized and native
crystal are used to calculate experimental phases. Recently,
the SIR phasing protocol has been re-applied in the radi-
ation damage-induced phasing (RIP) technique, where the
differences in intensities induced by radiation damage are
used as a phasing tool (Ravelli et al. 2003). Limitations of
these phasing protocols are mainly due to the deleterious
effect that a high X-ray dose has on a protein crystal. X-ray
radiation damage induces many changes to the protein
structure and to the solvent, resulting in a consistent
number of damaged sites and a decrease in the diffraction
quality of the crystal. As an alternative to X-rays, ultravi-
olet (UV) radiation has been used to induce specific
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changes in the macromolecule, which only marginally
affects the quality of the diffraction (Nanao and Ravelli
2006) while inducing more selective changes to the protein
structure. This method is known as UV-RIP (ultraviolet
radiation damage-induced phasing). The most striking
effect of UV radiation damage on protein crystals, as for
X-ray radiation, is the breakage of disulfide bonds. Fur-
thermore, this technique has been extended to a non-
disulfide-containing protein, photoactive yellow protein,
which contains a chromophore covalently attached through
a thioester linkage to a cysteine residue (Nanao and Ravelli
2006) and to selenomethionine (MSe) proteins (Panjikar
et al. 2011). Therefore, this method offers considerable
potential, and selenium-specific UV damage could serve as
an additional or even an alternative way of experimental
phasing in macromolecular crystallography (de Sanctis
et al. 2011). Another popular method adopted at SP centers
is the use of iodide ion soaks and SAD experiments for de
novo phasing (Abendroth et al. 2011).
Molecular replacement (MR) requires a search model
for the protein under investigation, either determined from
X-ray crystallography or from homology modeling, to
calculate initial estimates of the phases of the new struc-
ture. The use of MR has become more commonplace with
the expansion of the PDB and is currently used to solve up
to 70% of deposited macromolecular structures where a
homolog structure already exists (Fig. 7b: Pike et al. 2008).
In cases when there are up to four molecules in the
asymmetric unit of the crystal, the search model is struc-
turally similar to the target protein and its oligomeric state
is known, the MR method is fairly straightforward using
programs such as MOLREP (Vagin and Teplyakov 1997),
AMoRe (Navaza 2001) and Phaser (McCoy et al. 2007). To
further streamline the MR procedure, a number of
Fig. 7 Examples for widely
used structure determination
methods. a Structure of E. coli
Arabinose Isomerase (PDB




also shown (Manjasetty and
Chance 2006). b Structure of
DAPK3 (PDB 2J90) determined
with the molecular replacement
(MR) method using the template
prepared by homolog structures
(PDB 1YRT, 1JKT, 1WVX)
(Pike et al. 2008)
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automated MR pipelines have been developed. These
include the Bias Removal Server (Reddy et al. 2003),
CaspR (Claude et al. 2004), BRUTEPTF (Strokopytov
et al. 2005) and MR pipeline (Schwarzenbacher et al.
2008). Other developments include Auto-Rickshaw (Pan-
jikar et al. 2005) which is principally used for experimental
phasing, but also uses phased MR as well as enabling a
standard MR phasing protocol using BALBES (Long et al.
2008), MrBUMP (Keegan and Winn 2008) and a scheme
for using comparative models in MR (Raimondo et al.
2007). Recently, MR phasing has been demonstrated for
2.0 A˚ data based on the combination of localizing model
fragments such as small helices with Phaser and density
modification with SHELXE (Rodriguez et al. 2009). In
addition, improved MR by density-and energy-guided
structure optimization has also been described (DiMaio
et al. 2011).
It is worth noting that if an MR search is difficult pri-
marily because the model is extremely poor and the reso-
lution of the X-ray data is limited (lower than 2.0 A˚), then
the time spent attempting to obtain a solution with that
model is usually inversely proportional to the usefulness of
the solution once it has been obtained. This is partly
because the model suffers from bias and often requires
iterative, time-consuming manual correction using com-
puter graphics in combination with model refinement.
Interestingly, the determination of the substructure
becomes easier when an anomalous difference Fourier
synthesis can be calculated using preliminary phases from
an MR solution. The subsequent use of this substructure to
generate an unbiased electron density map (Baker et al.
1993) is often referred to as MRSAD (molecular replace-
ment with single-wavelength anomalous dispersion)
(Schuermann and Tanner 2003). A combination of MR and
SAD has been automated and incorporated into the struc-
ture determination platform Auto-Rickshaw. The complete
MRSAD procedure includes MR, model refinement,
experimental phasing, phase improvement and automated
model building; it has been shown that poor MR or SAD
phases with phase errors larger than 70 can be improved
using this described procedure (Panjikar et al. 2009) and a
large fraction of the model can be determined in a purely
automatic manner from X-ray data extending to better than
2.6 A˚ resolution.
Computational resources for structure determination
New software packages have been developed for deter-
mining the 3D structure of proteins to meet the HT
requirements of SP projects (Jain and Lamour 2010). The
software pipelines have varying degrees of automation
deriving from different aims, but all require minimum user
input to facilitate the automated location of heavy-atom
sites, phase determination and phase improvement by sol-
vent flipping/flattening, model building and refinement.
Ideally, the structure solution process should be carried out
in parallel with data processing. For instance, the most
recent iteration of the HKL suite, HKL-3000, is capable of
integrating automated data collection, processing, structure
solution and refinement steps (Minor et al. 2006). The
Auto-Rickshaw suite incorporates many widely used pro-
grams for automatic protein structure determination (Pan-
jikar et al. 2005). AutoSHARP (Vonrhein et al. 2007),
CRANK (Ness et al. 2004; Pannu et al. 2011), BnP (Weeks
et al. 2002), HKL2MAP for SHELX (Pape and Schneider
2004; Schneider and Sheldrick 2002) and the PHENIX
suite (Adams et al. 2004) are highly automated and provide
all the tools necessary to proceed from substructure solu-
tion and phasing through to displaying and interpreting the
resultant electron density map. In addition, these programs
provide automated protocols to enable protein models to be
built rapidly without user intervention, providing feedback
on the success of the experiment while the crystal is still at
or near the beamline. AutoSHARP includes various CCP4
(Collaborative Computational Project, number 4) programs
(Winn et al. 2011), uses the SHELXD software for locating
heavy atoms and carries out density modification using
either DM (Cowtan and Zhang 1999) or SOLOMON
(Abrahams and Leslie 1996), while ARP/wARP (Langer
et al. 2008; Morris et al. 2003) or BUCCANEER (Cowtan
2006) are used for automated model building. This pipeline
can be run without user intervention once suitable input has
been provided and can be rerun from any of the structure
solution steps by the user whenever desired. The CRANK
package invokes BP3 (Pannu and Read 2004), CRUNCH2
(de Graaff et al. 2001), SHELXD, SOLOMON, DM,
RESOLVE (Terwilliger 2000), BUCANEER and ARP/
wARP along with a few CCP4 programs and uses standard
XML input at every step of the structure solution. The
process may be invoked either using the CCP4 graphical
user interface (CCP4i) or off-line and the user must choose
the defined path through the pipeline. The BnP pipeline
includes SnB (Xu and Weeks 2008) and the PHASE
package for structure solution. HKL-3000 is a commer-
cially available software package, which includes the data-
processing programs DENZO/SCALEPACK (Otwinowski
and Minor 1997) along with structure solution programs
including modified versions of MLPHARE, SHELXC/D/E,
DM and ARP/wARP. The PHENIX software suite is a
highly automated system for macromolecular structure
determination that can rapidly arrive at an initial partial
model of a structure without significant human interven-
tion, given moderate resolution and good quality data. The
Auto-Rickshaw pipeline has been developed with its pri-
mary aim to validate the X-ray diffraction experiment
while the crystal is still at or near the synchrotron
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beamline. The software pipeline is optimized for speed so
that the user has the ability to evaluate their data in the
minimum possible time. Auto-Rickshaw makes use of
publicly available macromolecular crystallography soft-
ware. The entire process in the pipeline is fully automatic.
Each step of the structure solution process is governed by
the decision-making module within Auto-Rickshaw, which
attempts to mimic the decisions of an experienced crys-
tallographer for a number of phasing protocols (SAD,
MAD, RIP, MR and variations thereof). Once the input
parameters (number of amino acids, heavy atoms, mole-
cules per asymmetric unit, probable space group and
phasing protocol) and X-ray intensity data have been input
into Auto-Rickshaw, no further user intervention is
required. It proceeds step by step through the structure
solution using the decision makers. In cases where a
problem is encountered during the structure solution pro-
cess, the user is informed so that the data collection, the
data quality, space group ambiguity or optimization of the
anomalous signal is flagged as a problem. Once all the
steps have been run successfully, Auto-Rickshaw provides
a tarball, which includes all the necessary files to evaluate
the electron density map and model, including ready-made
scripts for the graphics programs COOT (Emsley and
Cowtan 2004; Emsley et al. 2010), O (Jones et al. 1991)
and XtalView (McRee and Israel 2008). The Auto-Rickshaw
server (http://www.embl-hamburg.de/Auto-Rickshaw) is
freely accessible to the SP community to aid in their pro-
tein structure determination effort.
Structure and function
Proteins play key roles in almost every biological process
and participate in a variety of physiological functions. The
key to unraveling how proteins perform their different roles
lies in understanding the relationship between protein
structure and function.
Computational tools and Web servers
A wiki, Proteopedia, provides the forum to contribute and
share information about a particular 3D structure to exploit
its functional role through collaboration, follow-up studies
and joint publication (Hodis et al. 2010; Prilusky et al.
2011). Many of the protein structures determined at SP
centers are ‘hypothetical proteins’ of unknown function.
Insights into the biochemical function of these proteins can
be derived by bioinformatics tools such as TOPSAN (The
Open Protein Structure Annotation Network), a Web-based
platform which facilitates collaborations that have resulted
in insightful structure–function analysis for many proteins
leading to numerous peer-reviewed publications (Ellrott
et al. 2011; Weekes et al. 2010). A number of other servers,
such as ProFunc (Laskowski et al. 2005), 3D-Fun (von
Grotthuss et al. 2008) and ProTarget (Sasson and Linial
2005), enable automated protein function annotations using
protein structures. These servers accept protein coordinates
in the standard PDB format and compare them with all
known protein structures in the PDB. If structural hits are
found for proteins of known function, they are listed
together with their function and some vital comparison
statistics. A recently developed platform called iSee
(interactive Structurally enhanced experience) allows the
interaction and annotation of novel structures and provides
a powerful tool for disseminating the full range of struc-
tural information. Interestingly, this platform is hosting and
featuring the animations adopted by journals that ‘fly’ the
reader through structural representations to specific
molecular features (Davis et al. 2010; Rellos et al. 2010).
This novelty in exposing structural knowledge across the
life sciences is one of the breakthroughs attributable to SP.
Protein fold, sequence motif, binding site, oligomeric state
and surface features for protein annotation
The 3D folding patterns of proteins can be categorized into
classes which allow inferences to be made about their
molecular function. A comparison of the 3D structures of
proteins of known function in the PDB has shown that
proteins sharing common folds are often evolutionarily
related. Protein folds are more highly conserved over time
than protein sequence, and structural similarities between a
protein of known function and a novel (hypothetical) pro-
tein implies that these proteins have related function
(Chothia and Lesk 1986). The most commonly used servers
for comparing the fold of a newly determined structure
against structures in the PDB are DALI at EMBL (Holm and
Sander 1999) and VAST (Vector Alignment Search Tool) at
NCBI (Gibrat et al. 1996). For example, the hypothetical
protein FLJ36880 has a fold which indicates that it is a
member of the fumarylacetoacetate hydrolase family
(Manjasetty et al. 2004b) and the fold of MJ0882 highly
resembles that of a methyltransferase despite limited
sequence similarity to any known methyltransferase (Huang
et al. 2002). Structural motifs in a protein usually represent
regions characteristic of specific functions (Godsey et al.
2007). For example, helix–turn–helix motifs are highly
conserved in DNA binding proteins. Similar functional sites
can be found across different folds in proteins as a result of
convergent evolution. This is frequently observed across
folds involving metal ions. The server PINTS (Patterns in
Non-homologous Tertiary Structures) helps to identify
functional patterns in non-homologous structures (Stark and
Russell 2003). For example, the crystal structure of YodA
from E. coli indicates that it is a metal-binding lipocalin-
like protein and it may be important in the metal stress
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response (David et al. 2003). In addition, the hypothetical
protein ybeY belongs to the UPF0054 family and binds a
metal ion. Its structure and sequence similarity to a number
of predicted metal-dependent hydrolases provides a func-
tional assignment for this protein (Zhan et al. 2005). The
crystal structure of Homo sapiens PTD012 reveals a zinc-
containing hydrolase fold (Manjasetty et al. 2006).
Proteins are a unique class of biological molecules in that
they can recognize and interact with diverse substances.
They contain complementary clefts and surfaces designed
to bind to specific molecules. The identification of binding
sites on the surface of proteins can give insights into bio-
logical function. There are many programs available for
detecting and visualizing binding sites on the surface of
proteins including SURFNET (Laskowski 1995), CAVER
(Petrek et al. 2006) and dxTuber (Raunest and Kandt 2011).
For example, the crystal structure of TTHB192 does not
have the same signature sequence motif as the RNA rec-
ognition motif domain, however, the presence of an evo-
lutionarily conserved basic patch on the b-sheet could be
functionally relevant for nucleic acid binding (Ebihara et al.
2006). The structure for a representative of UPF0044, E.
coli YhbY, possesses an IF3C-like core fold which is
common in several RNA-binding proteins. Members of
UPF0044 possess a basic surface on their b-sheet face and a
proximal GKxG loop that are suggestive of an RNA rec-
ognition surface (Ostheimer et al. 2002). If the binding site
is occupied by a small molecule carried over from the
crystallization buffer or protein purification, then it is often
easy to detect the functional ‘‘hot spot’’ in the protein
structure. For example, TM841 is a 35-kDa protein com-
prising two separate domains with a novel fold. Therefore,
it was not possible to derive any clues about this protein’s
function from a comparison with proteins in the PDB.
However, the electron density map clearly showed the
presence of a fatty acid molecule bound in a pocket between
the two protein domains, suggesting that TM841 may play a
role in fatty acid transport or metabolism (Schulze-Gahmen
et al. 2003). In a second example, ligands bound to the
structures of p14.5, TdcF and Rv2704, which belong to the
highly conserved YjgF/YER057c/UK114 protein super-
family, clearly indicated the presence of a functionally
important substrate binding site. The structure of human
p14.5 contains at least one benzoic acid molecule per site
forming bi-dentate interactions between its carboxylate
moiety and the guanidinium group of a strictly conserved
arginine, Arg107 (Manjasetty et al. 2004a). Furthermore,
the bonds to the ligands in the TdcF crystal structure clearly
highlight the importance of the conserved residues (Burman
et al. 2007). Residue conservation in an amino acid
sequence or related proteins is a strong indicator of func-
tionally important sites. Given a multiple sequence align-
ment of one protein against all related proteins, it is possible
to determine the level of sequence conservation. Once a
‘conservation score’ for each residue in the protein has been
calculated, it is useful to map these scores onto its 3D
structure to see whether certain regions of the structure are
more highly conserved than others. It has been demon-
strated that clusters of highly conserved residues on the
surface of proteins can reliably identify ligand-binding sites
or protein–protein interaction sites. For example, the amino
acid conservation pattern and observed metal-binding site
in the crystal structure of E. coli YcDX indicates the loca-
tion of its putative active site. All residues involved in metal
coordination are invariant in the YcdX family, highlighting
their functional importance (Teplyakov et al. 2003). An in-
depth study is warranted to check the reliability of these
ligand-binding discovery programs. The ligand or metal-
binding sites observed through computational approaches
can be further verified by obtaining experimental data. For
example, in a recent study, a combination of experimental
and bioinformatics approaches has provided a comprehen-
sive active site analysis on the genome scale for metallo-
proteins, revealing new insights into their structure and
function (Shi et al. 2011).
The arrangement of molecules in the asymmetric unit of
the crystal and analysis of the accessible surface area
buried at the subunit interfaces can be used to identify the
most likely biological unit (oligomeric state) for a protein.
The evolutionarily conserved trimeric structure of CutA1
proteins suggests a role in signal transduction (Arnesano
et al. 2003). The functional annotation of the large number
of structures of hypothetical proteins was published based
on a bioinformatics approach (Shin et al. 2007; Yakunin
et al. 2004). Therefore, crystal structures can provide
insights into biological function even in the absence of any
other biochemical data. However, the protein structure
alone will provide conclusive functional annotation only in
a limited number of cases. Therefore, SP centers collabo-
rate with academic laboratories to resolve important
questions in biology and disease. In this approach, highly
organized networks of investigators apply the new para-
digm of HT structure determination, which has been suc-
cessfully developed at SP centers during the past decade, to
study a broad range of important biological and biomedical
problems. One such example is the NIH-funded Enzyme
Function Initiative (http://enzymefunction.org).
Information management
SP data are hard to manage due to their complexity and the
fact that different parts of the structure determination
process on the same protein target are often performed at
different laboratories as a collaborative effort. The file-
based communications and data transactions become time
consuming and sometimes unmanageable. Efficient data
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management techniques have been developed at SP centers
to keep track of the enormous amount of data generated,
which minimize duplication of effort and maximize the
chances of success at each step (Haquin et al. 2008).
Notable laboratory information management systems
(LIMS) of SP centers include Sesame (Zolnai et al. 2003),
HalX (Prilusky et al. 2005), PiMS (Morris et al. 2011),
SPEX Db (Raymond et al. 2004) and IceDB. All the SP
centers have developed their own data management sys-
tems and are linked to a centralized target registration
database, TargetDB (Chen et al. 2004) hosted by the PDB.
PepcDB, an extension of TargetDB, allows groups to report
protocols and experimental details (Pan et al. 2007). Sub-
sequently, the Protein Structure Initiative Knowledgebase
(PSIKB) was created by integrating TargetDB and PepcDB
to turn the products of the SP effort into knowledge that
can be accessed by the life sciences community (Berman
et al. 2009). Furthermore, a Structural Biology Knowl-
edgebase (SBKB) web resource (http://www.sbkb.org) has
recently been developed to aid protein research with
improved features to foster collaborations between the
biological community and SP centers (Gabanyi et al.
2011).
Structural proteomics for biology
Structural knowledge of a protein clearly provides clues
relating to its biological activity and physiological role. SP
is one of the recent technologies that promotes drug dis-
covery and biotechnological applications. Structural
information can be used in many ways to ascertain the
functional properties of cellular components. One of the
crucial components for understanding the functions of
novel proteins is the analysis of their experimental or
modeled 3D structures. SP centers have provided an
enormous impetus for methods development in structural
biology and many laboratories are now actively imple-
menting these technologies.
Follow-on research
Scientists and engineers are now involved in utilizing
structural knowledge of proteins generated by the SP
approach as a basis for understanding protein function to
utilize proteins in various technological applications as fol-
low-on research. For instance, in Europe, the emphasis of the
Structural Proteomics IN Europe (SPINE2; http://www.
spine2.eu/SPINE2/index.jsp) initiative has been to apply HT
technologies to systems of biological interest, the ultimate
aim being to solve significant problems more effectively.
Recently, INSTRUCT (http://www.structuralbiology.eu/)
has started offering scientists access to world-class structural
biology and SP infrastructures and expertise that makes such
integration possible more rapidly, creating a coherent forum
for structural biology. This forum will stimulate closer col-
laboration between scientific communities and initiatives in
the life sciences. For instance, in Germany, one of the
INSTRUCT centers, the Protein Sample Production Facility
(http://www.pspf.de) of the Helmholtz association, provides
HT E. coli protein expression and large-scale production
technology with animal cell lines for European structural
biologists. The HT Crystallization platform at the EMBL
Grenoble Outstation, France, offers automated crystalliza-
tion to European researchers. Eleven facilities from across
Europe provide installations for applications including
macromolecular X-ray crystallography data collection.
BioStruct-X (http://www.biostructx.org/) cooperates with
INSTRUCT aiming to provide an integrated and coordinated
technology platform to all relevant methods in structural
biology.
In the USA, the goal of the PSI:Biology project is to
apply the paradigm of HT structure determination via
highly organized networks of investigators to solve the 3D
structure of proteins and macromolecular complexes rep-
resenting significant biological and biomedical problems.
For instance, a protein family specific platform, GPCR
(G-protein coupled receptor) network (http://gpcr.scripps.
edu/) was established to determine the high-resolution
structure and function of GPCRs distributed broadly across
the phylogenetic family tree. GPCRs mediate many
important cellular signal transduction events related to
differentiation, proliferation, angiogenesis, cancer, devel-
opment and cell survival. GPCRs represent the targets for
60–70% of drugs currently in development. The recent
progress and success in the structure determination of
GPCRs by utilizing SP technologies like LCP (Lipidic
Crystal Phase) crystallization (Cherezov 2011) and micro-
crystallography technologies for data collection (10 9 10
lm beam size, microfocus beamline, Pilatus 6 M detector)
have been described (Cherezov et al. 2009; Shimamura
et al. 2011). In addition, HT-enabled structural biology
partnerships have also been established. For example, the
IFN (Immune Function Network), a consortium of immu-
nologists, geneticists, computational biochemists and HT
structural biologists, is committed to the coordinated
structural, in vitro biochemical and in vivo functional
analyses of secreted molecules and ectodomains of cell
surface molecules which control adaptive and innate
immunity (Chattopadhyay et al. 2009). The research
activities of the IFN will be conducted in collaboration
with the NYSGRC (http://www.nysgxrc.org/). The TB
Structural Genomics Consortium is a worldwide consor-
tium of scientists developing a foundation for tuberculosis
diagnosis and treatment by determining the 3D structures
of proteins from Mycobacterium tuberculosis (Mtb). The
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consortium seeks to solve structures of proteins that are of
great interest to the TB biology community (http://www.
webtb.org/) (Musa et al. 2009). Tuberculosis poses a global
health emergency, which has been compounded by the
emergence of drug-resistant Mtb strains. For instance, the
protein structure of isocitrate lyase, a persistence factor of
Mtb (Sharma et al. 2000), has been extensively studied and
advances in technology have enabled the assembly of HT
pipelines that can be used for the development of glyoxy-
late cycle inhibitors as new drugs for the treatment of this
disease (Munoz-Elias and McKinney 2005). Further, as a
step toward the better integration of protein 3D structural
information in cancer systems biology, NESG has con-
structed a HCPIN (Human Cancer Pathway Protein
Interaction Network) by analzsing several classical cancer-
associated signaling pathways and their physical protein–
protein interactions (Huang et al. 2008).
Systems biology and biotechnology
In systems biology, proteins are visualized as a network of
interconnected dots. To understand the complexity of cel-
lular function, one should know the detailed 3D behaviors
of all the available dots which form the basis of life. Fur-
thermore, the structures of these proteins could provide
quantitative parameters to help elucidate functional net-
works through knowledge of protein function, evolution
and interactions. The protein structures generated by SP
can be used for the assignment of domain structure, func-
tional annotation and the prediction of interaction partners
in biochemical pathways (Harrill and Rusyn 2008). The
structural information can be used to further characterize
large-scale protein interaction networks by providing the
key functional properties of cellular components (Beltrao
et al. 2007).
Biotechnology embraces the bioproduction of fuels and
chemicals from renewable sources. Sustainable energy is a
major problem in the twenty-first century. If biofuels are to
be part of the solution, this field must accept a degree of
scrutiny unprecedented in the development of a new
industry. That is because sustainability deals explicitly with
the role of biofuels in insuring the well-being of our planet,
our economy and our society, both today and in the future.
The development of detailed kinetic models that include
accurate regulatory network parameters will facilitate the
identification of enzymatic bottlenecks in the metabolic
pathways that could be harnessed to achieve biofuels
overproduction. The latest advances in SP will continue to
identify the biocatalysts, which power the development of
enzyme reactors for producing substantial amounts of
biofuels (Daniels et al. 2011). Some biomolecules are
robust enough to be used in biotechnological applications.
For instance, enzymes can be used to break down starch to
form sweeteners. The structure–function relationship of E.
coli arabinose isomerase, ECAI, advanced its application in
tagatose (a new sweetener) production (Manjasetty et al.
2010; Manjasetty and Chance 2006) (Fig. 7a).
Nanobiotechnology is a novel branch of futuristic sci-
ence and engineering. A nanobiomachine is a machine
formed by a biomolecule with a nanoscale diameter. The
knowledge of a protein sequence provides the basis for
understanding these nanobiomachines, which ultimately
describe its functional significance. The structural and
functional knowledge of a protein is essential to utilize
proteins in nanotechnology applications and to develop
bionanodevices. Glucose oxidase is a small, stable enzyme
that oxidizes glucose into glucolactone, converting oxygen
into hydrogen peroxide in the process. It is used as the
heart of biosensors that measure the amount of glucose in
the blood. Insights from protein structure can be crucial in
engineering proteins for nanotechnology applications.
Models of protein structures and drug design
SP projects around the globe were established to determine
the structures of proteins in an HT, automated fashion.
However, despite the advances made by SP organizations
in terms of automation, throughput and methodology
development, the structures of certain classes of proteins,
such as membrane proteins, are still notoriously difficult to
determine. This warrants alternative techniques to generate
models for these proteins to enhance our understanding of
their physical and chemical properties. This has led to the
development of a large number of bioinformatics tools
capable of generating models for these novel proteins.
Among them, MODELLER (Eswar et al. 2008) and
ROSETTA (Das and Baker 2008) represent two of the best
protein structure prediction servers. MODELLER generates
a model of an unknown protein using a template structure
generated by the SP approach, whereas ROSETTA provides
ab initio structure prediction of the unknown protein.
Biomodeling provides the ability to understand the physi-
cochemical properties of proteins of biomedical impor-
tance with undetermined 3D structures. It involves a range
of computerized techniques based on quantum physics and
experimental proteomics data to predict and correlate
biological properties at the molecular level. Statistical and
regression analysis techniques are the best methodologies
and are capable of predicting geometries, energies, and
electronic and spectroscopic properties. Homology-based
modeling, as applied by MODELLER and ROSETTA, relies
on sequence alignments between proteins of known struc-
ture and the target protein. The accuracy of the calculated
model is dependent on the accuracy of the sequence
alignment and the divergence between target and template.
The most accurate alignments are obtained by iterative and
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profile or HMM (Hidden Markov Models)-based methods.
In addition, structural data can be used to verify and
improve alignments.
Biomodeling has become a valuable and essential tool in
the drug design and discovery process. Drug design is a 3D
puzzle where small drug molecules are fitted into the active
site of a protein. The factors which affect protein–ligand
interactions can be characterized by molecular docking and
studying quantitative structure activity relationships
(QSAR). Traditionally, drug discovery relies on a stepwise
synthesis and screening of large numbers of compounds to
optimize drug activity profiles. The design of new and
more potent drugs against diseases such as cancer, AIDS
and arthritis can be aided using bioinformatics tools such as
computer-assisted drug design (CADD) or computer-
assisted molecular design (CAMD). Structural bioinfor-
matics tools not only have the potential to build predictive
models of the proteins of biomedical interest, but also help
to bring new drugs to market. Complementary in silico
methods, such as structure-based drug design (SBDD),
incorporate the knowledge from high-resolution 3D protein
structures generated by SP to probe structure–function
relationships, identify and select therapeutically relevant
targets (assessing druggability), study the molecular basis
of protein–ligand interactions, characterize binding pock-
ets, develop target-focused compound libraries, identify
hits by HT docking (HTD) and optimize lead compounds,
all of which can be used to rationalize and increase the
speed and cost-effectiveness of the drug discovery process.
An analysis of the results obtained by several docking and
modeling programs has shown that, in most cases, they can
work well. Most of the programs used in drug discovery
have incorporated subroutines to identify false positives or
negatives using scoring functions, which has led to a sig-
nificant improvement in hit rates.
Conclusion
Contributions from SP are mainly twofold: first, novel
structural information has been generated to understand the
proteome of various organisms; second, innovative HT
technologies have been developed for protein structure
determination. These technologies and related structural
information have, in turn, been exploited by biologists in
many different ways in broad areas of life sciences
research. However, structural knowledge alone is not suf-
ficient to fully understand a protein’s cellular role. Hence, a
major bottleneck is studying a protein’s behavior and
dynamics within larger macromolecular assemblies and
protein–protein interactions within a cellular pathway.
Research such as this will drive the application of SP in the
decades that follow.
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